Glofitamab Step-up Dosing Induces High Response Rates in Patients with Hard-to-Treat Refractory or Relapsed Non-Hodgkin Lymphoma
暂无分享，去创建一个
E. Piccione | C. Carlo-Stella | M. Crump | M. Hutchings | M. Dickinson | F. Morschhauser | F. Offner | J. Martínez-López | D. Carlile | E. Bachy | M. Dixon | K. Humphrey | G. Iacoboni | L. Lundberg | J. Relf | A. Balari | D. P. Callejo | G. Iacoboni